We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelleniq Gds S Regulatory News (HLPD)

Share Price Information for Helleniq Gds S (HLPD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11.075
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 11.075
High: 0.00
Low: 0.00
Prev. Close: 11.075
HLPD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

8 Nov 2018 15:31

RNS Number : 8254G
Hellenic Petroleum S.A.
08 November 2018
 

PRESS RELEASE

8 November 2018

 

Third Quarter / Nine month 2018 financial results

 

 

Record high 9M18 reported Net Income (+32%) and exports; stronger profitability, increased production and sales in 3Q18.

 

HELLENIC PETROLEUM Group announced its 3Q and 9M financial results. 3Q17 Reported EBITDA came in at €258 m (+12%), leading 9M to a record high of €731 m (+20%). IFRS Reported Net Income amounted to €135 m (+28%) in Q3 and €360 m (+32%) in 9M, the highest on record, with Earnings per Share (EPS) at 1.18.

Higher sales volumes and crude prices led 9M18 sales revenues at €7.3 bn (+ 25%).

Likewise, excluding the impact of increasing crude oil prices on inventory and one-off items, 3Q18 Adjusted EBITDA reached €237m, (+15%), while 9M18 came in at €574 m, with Adjusted Net Income at €111m (+25%) in 3Q18 and €239m in 9M18 (-23%).

The main driver for improved 3Q18 operating profitability was strong refining performance which, through increased mechanical availability, normalised operations and optimal crude selection, delivered the highest ever overperformance vs benchmark refining margins of $7.3/bbl. Equally, the significant increase in production vs 3Q17 (4m MT, +19%), led total sales higher by 8% and exports by 27%. Operating performance outweighed the significant decline in benchmark refining margins by 20%, as well as the cost of increased CO2 emissions rights provisions. Regarding feedstock supply, following the re-imposition of US sanctions, the Group substituted Iranian crude with alternative crude oil types, a switch that did not affect performance adversely.

As a result, 9M18 production rose to 11.7 m tons (+ 5%) and sales volumes to 12.4 m tons (+ 3%) with exports at 7.1 m tons, accounting for 57% of total sales.

The Group's financial position strengthened further, with finance cost 13% lower in 9M18 and 11% in 3Q18, following the successful completion of the 2018 refinancing program.

3Q18 operating cashflow (Adj. EBITDA - Capex) amounted to €203 m, the highest since 1Q17, bringing Net Debt at €1.8bn, lower q-o-q and gearing at 40%, the lowest level in the last 2.5 years.

Based on 9M18 reported results, the Board of Directors approved the distribution of €0.25/share as interim dividend for 2018.

 

 

High and volatile crude oil prices, strong USD sustained

US sanctions on Iran, combined with increased production in North America, led 3Q18 crude oil prices averaging $76/bbl, flat vs 2Q18, but significantly higher compared to 3Q17 (+46%). Prices were volatile, recording their highest level since 2014, at the end of 3Q18.

Macro and political developments in Eurozone and the US resulted in a further strengthening of USD against the euro q-o-q, averaging $1.16, flat vs 3Q17 ($1.17).

Product cracks, excluding diesel, were weaker compared to 3Q17, leading the Med benchmark refining margins 20% lower, with FCC benchmark at $5.7/bbl vs $7.1/bbl last year, while decline was lower for Hydrocracking margins, which averaged $5.6/bbl (3Q 2017 $5.9/bbl).

 

Increased aviation fuels demand

Total domestic fuels demand was 1.6 m tones, - 1% vs 3Q17. The marine and aviation market recorded an increase of 3%, with a significant improvement in aviation fuels market (+ 10%), due to tourism.

 

Important developments

In E&P, the lease agreements for "Block 10 - Kyparissiakos Gulf" (HELPE 100%) and two offshore areas west and southwest of Crete, (HELPE 20%, Total 40% - operator, ExxonMobil 40%) were finalized, pending formal signing and customary approvals.

With regards to DESFA sale, the spin-off of DESFA from DEPA through an in kind share capital reduction of DEPA, in exchange for DESFA shares to owners HRADF and HELPE is in process, while the certification of DESFA from energy regulatory authorities is pending. The transaction is expected to be completed in the next quarter. The proceeds of the sale, net of applicable taxes, will be applied mostly towards repaying existing debt, while an extraordinary dividend may also be considered.

In the context of DEPA Group's reorganization of distribution and marketing activities, the acquisition of remaining 49% of EPA and EDA Attikis from Attiki Gas (subsidiary of Shell Gas BV) is expecting approvals from competition authorities.

Key highlights and contribution for each of the main business units in 3Q18 were:

 

REFINING, SUPPLY & TRADING

- Refining, Supply & Trading 3Q18 Adjusted EBITDA at €173m (+25%), with 9M18 at €423 m (-17%).

- The improved operation of the refineries in 3Q18 led to an increase in production and sales to 4 m tons (+19%) and 4.1 m tons (+8%) respectively.

- HELPE 3Q18 realised margin amounted to $12.1/bbl, mainly on taking advantage of opportunities in crude pricing structure.

- Crude slate differentiation had an impact on product yields as well, with middle distillates at 52%, while fuel oil was reduced at 10%.

 

PETROCHEMICALS

- Higher sales volumes of polypropylene (+5%) and increased contribution of the Aspropyrgos refinery propylene unit led to increased profitability, with Adjusted EBITDA at €25 m (+5%).

 

MARKETING

- 3Q18 Marketing Adjusted EBITDA at €42 m and 9M18 at €81 m.

- Increased aviation fuels volumes maintained 3Q18 profitability at similar levels vs 3Q17, with Domestic Marketing Adjusted EBITDA at €26 m (-3%).

- Weaker margins in most markets where the Group operates, had a negative impact on International Marketing profitability, with 3Q18 Adjusted EBITDA at €16 m (-14%).

 

ASSOCIATED COMPANIES

- DEPA Group participation to consolidated Net Income came in at €7m.

- Elpedison EBITDA amounted to €4 m (+82%), due to improved Retail contribution.

 

 

 

Key consolidated financial indicators (prepared in accordance with IFRS) for 3Q18 are shown below:

€ million

3Q17

3Q18

% Δ

9M17

9M18

% Δ

P&L figures

 

 

 

 

 

 

Refining Sales Volumes ('000 ΜΤ)

3,787

4,087

8%

11,991

12,354

3%

Sales

1,823

2,674

47%

5,888

7,341

25%

EBITDA

230

258

12%

608

731

20%

Adjusted EBITDA 1

206

237

15%

663

574

-14%

Net Income

106

135

28%

273

360

32%

Adjusted Net Income 1

89

111

25%

313

239

-23%

Balance Sheet Items

 

 

 

 

 

 

Capital Employed

 

 

 

4,142

4,421

7%

Net Debt

 

 

 

1,811

1,773

-2%

Debt Gearing (ND/ND+E)

 

 

 

44%

40%

 

 

Notes:1. Calculated as Reported adjusted for inventory effects and other non-operating items.

 

 

Further information:

V. Tsaitas, Investor Relations Officer

Tel.: +30-210-6302399

Email: vtsaitas@helpe.gr

 

 

Group Consolidated statement of financial position

 

 

 

As at

 

Note

30 September 2018

31 December 2017

ASSETS

 

 

 

Non-current assets

 

 

 

Property, plant and equipment

10

3.261.709

3.311.893

Intangible assets

11

106.354

105.684

Investments in associates and joint ventures

 

704.346

701.635

Deferred income tax assets

 

67.260

71.355

Investment in equity instruments

2,3

839

1.857

Loans, advances and long term assets

 

84.380

89.626

 

 

4.224.888

4.282.050

Current assets

 

 

 

Inventories

12

1.211.620

1.056.393

Trade and other receivables

2,13

938.400

791.205

Assets held for sale

10

3.600

-

Derivative financial instruments

3

21.925

11.514

Cash, cash equivalents and restricted cash

14

1.053.450

1.018.913

 

 

3.228.995

2.878.025

 

 

 

 

 

 

 

 

Total assets

 

7.453.883

7.160.075

 

 

 

 

EQUITY

 

 

 

Share capital and share premium

15

1.020.081

1.020.081

Reserves

16

268.407

358.056

Retained Earnings

 

1.294.875

930.522

Capital and reserves attributable to owners of the parent

 

2.583.363

2.308.659

Non-controlling interests

 

63.864

62.915

Total equity

 

2.647.227

2.371.574

 

 

 

 

LIABILITIES

 

 

 

Non-current liabilities

 

 

 

Borrowings

17

1.424.034

920.234

Deferred income tax liabilities

 

169.592

131.611

Retirement benefit obligations

 

149.404

133.256

Provisions for other liabilities and charges

 

4.344

6.371

Trade and other payables

 

26.446

28.700

 

 

1.773.820

1.220.172

Current liabilities

 

 

 

Trade and other payables

18

1.523.280

1.661.457

Income tax payable

 

105.539

5.883

Borrowings

17

1.403.323

1.900.269

Dividends payable

 

694

720

 

 

3.032.836

3.568.329

Total liabilities

 

4.806.656

4.788.501

Total equity and liabilities

 

7.453.883

7.160.075

 

 

 

Group Consolidated statement of comprehensive income

 

 

 

For the 9 month period ended

For the 3 month period ended

 

Note

30 September 2018

30 September 2017

30 September 2018

30 September 2017

Sales

4

7.341.129

5.888.487

2.674.220

1.822.785

Cost of sales

 

(6.420.913)

(5.109.442)

(2.349.606)

(1.546.631)

Gross profit

 

920.216

779.045

324.614

276.154

Selling and distribution expenses

 

(234.407)

(198.401)

(79.945)

(64.914)

Administrative expenses

 

(104.294)

(93.852)

(37.899)

(30.807)

Exploration and development expenses

 

(660)

(249)

(631)

(40)

Other operating income/(expenses) and other gains/(losses)-net

5

7.176

(17.540)

2.529

(2.842)

Operating profit

 

588.031

469.003

208.668

177.551

Finance income

 

2.783

3.020

1.034

582

Finance expense

 

(114.569)

(131.413)

(36.804)

(40.875)

Currency exchange gains/ (losses)

6

2.540

(8.317)

(1.988)

(1.468)

Share of profit of investments in associates and joint ventures

7

28.484

34.956

13.402

4.297

Profit before income tax

 

507.269

367.249

184.312

140.087

Income tax expense

8

(147.341)

(94.043)

(49.556)

(34.525)

Profit for the period

 

359.928

273.206

134.756

105.562

Other comprehensive income/ (loss) :

 

 

 

 

 

Items that will not be reclassified to profit or loss:

 

 

 

 

 

Actuarial losses on defined benefit pension plans

16

(7.579)

(2.219)

(7.579)

-

Changes in the fair value of equity instruments

2, 16

(524)

849

(82)

(1.276)

Reduction in value of land

 

-

(1.669)

-

-

 

 

(8.103)

(3.039)

(7.661)

(1.276)

Items that may be reclassified subsequently to profit or loss:

 

 

 

 

 

Derecognition of (losses) / gains on hedges through comprehensive income

16

(14.920)

1.979

-

-

Fair value gains /(losses) on cash flow hedges

16

21.537

(13.014)

5.281

8.416

Currency translation differences and other movements

16

(481)

577

(355)

412

 

 

6.136

(10.458)

4.926

8.828

Other comprehensive income/(loss) for the period, net of tax

 

(1.967)

(13.497)

(2.735)

7.552

Total comprehensive income for the period

 

357.961

259.709

132.021

113.114

Profit attributable to:

 

 

 

 

 

Owners of the parent

 

356.936

270.905

133.325

103.454

Non-controlling interests

 

2.992

2.301

1.431

2.108

 

 

359.928

273.206

134.756

105.562

Total comprehensive income attributable to:

 

 

 

 

 

Owners of the parent

 

354.967

258.101

130.650

110.885

Non-controlling interests

 

2.994

1.608

1.371

2.229

 

 

357.961

259.709

132.021

113.114

Basic and diluted earnings per share(expressed in Euro per share)

9

1,17

0,89

0,44

0,34

 

Group Consolidated statement of cash flows

 

 

 

For the 9 month period ended

 

Note

30 September 2018

30 September 2017

Cash flows from operating activities

 

 

 

Cash generated from operations

19

296.902

284.711

Income tax received/(paid)

 

(2.571)

(5.626)

Net cash generated from operating activities

 

294.331

279.085

 

 

 

 

Cash flows from investing activities

 

 

 

Purchase of property, plant and equipment & intangible assets

10,11

(94.985)

(137.539)

Proceeds from disposal of property, plant and equipment & intangible assets

 

227

401

Settlement of consideration of acquisition of further equity interest in subsidiary

24

(16.000)

-

Purchase of subsidiary, net of cash acquired

24

(1.298)

-

Grants received

 

80

-

Interest received

 

2.783

3.020

Dividends received

 

24.023

19.346

Investments in associates - net

 

-

(147)

Proceeds from disposal of investments in equity instruments

 

263

-

Net cash used in investing activities

 

(84.907)

(114.919)

 

 

 

 

Cash flows from financing activities

 

 

 

Interest paid

 

(99.981)

(126.677)

Dividends paid to shareholders of the Company

 

(74.479)

(59.578)

Dividends paid to non-controlling interests

 

(2.061)

(2.561)

Movement in restricted cash

14

144.445

11.873

Acquisition of treasury shares

16

(560)

(10.245)

Participation of minority shareholders in share capital increase of subsidiary

 

17

76

Proceeds from borrowings

 

408.089

285.800

Repayments of borrowings

 

(409.726)

(473.400)

Net cash generated from/ (used in) financing activities

 

(34.256)

(374.712)

 

 

 

 

Net increase/(decrease) in cash and cash equivalents

 

175.168

(210.546)

 

 

 

 

Cash and cash equivalents at the beginning of the period

14

873.261

924.055

Exchange gains/(losses) on cash and cash equivalents

 

3.813

(9.464)

Net increase/(decrease) in cash and cash equivalents

 

175.168

(210.546)

Cash and cash equivalents at end of the period

14

1.052.242

704.045

 

Parent Company Statement of Financial Position

 

 

 

As at

 

Note

30 September 2018

31 December 2017

ASSETS

 

 

 

Non-current assets

 

 

 

Property, plant and equipment

9

2.679.748

2.719.172

Intangible assets

10

6.447

7.042

Investments in subsidiaries, associates and joint ventures

 

689.372

671.622

Investment in equity instruments

3

460

1.252

Loans, advances and long-term assets

 

21.635

19.686

 

 

3.397.662

3.418.774

 

 

 

 

Current assets

 

 

 

Inventories

11

1.108.231

963.746

Trade and other receivables

12

1.087.558

989.901

Derivative financial instruments

3

21.925

11.514

Cash, cash equivalents and restricted cash

13

878.900

813.251

 

 

3.096.614

2.778.412

Total assets

 

6.494.276

6.197.186

 

 

 

 

EQUITY

 

 

 

Share capital

14

1.020.081

1.020.081

Reserves

15

272.785

360.694

Retained Earnings

 

771.059

428.448

Total equity

 

2.063.925

1.809.223

 

 

 

 

LIABILITIES

 

 

 

Non-current liabilities

 

 

 

Borrowings

16

1.454.547

909.579

Deferred income tax liabilities

 

131.262

89.959

Retirement benefit obligations

 

117.257

104.331

Derivative financial instruments

 

-

-

Provisions for other liabilities and charges

 

2.291

6.058

Trade and other payables

 

14.897

15.569

 

 

1.720.254

1.125.496

Current liabilities

 

 

 

Trade and other payables

17

1.413.156

1.554.027

Current income tax liabilities

 

100.878

2.769

Borrowings

16

1.195.369

1.704.951

Dividends payable

 

694

720

 

 

2.710.097

3.262.467

Total liabilities

 

4.430.351

4.387.963

Total equity and liabilities

 

6.494.276

6.197.186

 

 

 

Parent Company Statement of Comprehensive Income

 

 

 

For the 9 month period ended

For the 3 month period ended

 

Note

30 September 2018

30 September 2017

30 September 2018

30 September 2017

 

 

 

 

 

 

Sales

4

6.734.332

5.322.795

2.411.682

1.598.741

Cost of sales

 

(6.068.484)

(4.795.134)

(2.191.231)

(1.425.204)

Gross profit

 

665.848

527.661

220.451

173.537

Selling and distribution expenses

 

(71.742)

(44.123)

(23.610)

(12.352)

Administrative expenses

 

(64.675)

(56.249)

(24.533)

(19.101)

Exploration and development expenses

 

(834)

(95)

(672)

(29)

Other operating income/(expenses) & other gains/(losses)-net

5

3.963

(24.571)

2.919

(3.502)

Operating profit

 

532.560

402.623

174.555

138.553

Finance income

 

7.026

9.278

2.412

2.983

Finance expense

 

(105.089)

(118.303)

(33.505)

(36.742)

Dividend income

 

35.083

33.724

-

-

Currency exchange losses

6

2.721

(8.625)

(1.522)

(1.601)

Profit before income tax

 

472.301

318.697

141.940

103.193

Income tax expense

7

(139.575)

(83.559)

(42.941)

(29.156)

Profit for the period

 

332.726

235.138

98.999

74.037

Other comprehensive income / (loss):

 

 

 

 

 

Items that will not be reclassified to profit or loss:

 

 

 

 

 

Acruarial losses on defined benefit pension plans

15

(6.200)

(1.775)

(6.200)

-

Changes in the fair value of equity instruments

15

(565)

804

(97)

(1.325)

 

 

(6.765)

(971)

(6.297)

(1.325)

Items that may be reclassified subsequently to profit or loss:

 

 

 

 

 

Fair value gains / (losses) on cash flow hedges

15

(8.303)

(13.014)

(24.559)

8.416

Derecognition of gains/(losses) on hedges through comprehensive income

15

14.920

1.979

29.840

-

 

 

6.617

(11.035)

5.281

8.416

Other Comprehensive income / (loss) for the period, net of tax

 

(148)

(12.006)

(1.016)

7.091

Total comprehensive income for the period

 

332.578

223.132

97.983

81.128

Basic and diluted earnings per share(expressed in Euro per share)

8

1,09

0,77

0,32

0,24

 

 

 

Parent Company Statement of Cash flows

 

 

 

For the 9 month period ended

 

Note

30 September 2018

30 September 2017

Cash flows from operating activities

 

 

 

Cash generated from operations

18

258.838

219.205

Income tax received / (paid)

 

2.224

(20)

Net cash generated from operations

 

261.062

219.185

 

 

 

 

Cash flows from investing activities

 

 

 

Purchase of property, plant and equipment & intangible assets

9,10

(63.368)

(110.018)

Dividends received

 

35.083

33.724

Interest received

 

7.026

9.278

Settlement of consideration of acquisition of further equity interest in subsidiary

23

(16.000)

-

Participation in share capital increase of subsidiaries & associates

23

(21.054)

(3.917)

Net cash used in investing activities

 

(58.313)

(70.933)

 

 

 

 

Cash flows from financing activities

 

 

 

Interest paid

 

(92.376)

(128.829)

Dividends paid

 

(74.480)

(59.578)

Loans to affiliated companies

 

(2.925)

-

Movement in restricted cash

13

144.445

11.873

Acquisition of treasury stock

15

(561)

(10.245)

Proceeds from borrowings

 

436.284

303.157

Repayments of borrowings

 

(406.857)

(446.937)

Net cash generated from / (used in) financing activities

 

3.530

(330.559)

 

 

 

 

Net decrease in cash and cash equivalents

 

206.279

(182.307)

 

 

 

 

Cash and cash equivalents at the beginning of the period

13

667.599

731.258

Exchange losses on cash and cash equivalents

 

3.815

(8.625)

Net decrease in cash and cash equivalents

 

206.279

(182.307)

Cash and cash equivalents at end of the period

13

877.693

540.326

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRTZMMGMKRMGRZM
12
Date   Source Headline
29th Feb 20244:25 pmRNSHELLENiQ ENERGY_Annoucement 4Q/FY23 Fin. Results
2nd Nov 20235:36 pmRNS3rd Quarter Results
31st Aug 20234:20 pmRNSSecond Quarter / First Half 2023 financial results
18th May 20233:46 pmRNS1st Quarter Results
24th Feb 20234:03 pmRNSHELLENiQ ENERGH 4Q / FY 2022 financial results
10th Nov 20224:17 pmRNS3rd Quarter Results
27th Sep 20225:04 pmRNSChange of Name
25th Aug 20223:49 pmRNS2022 Half-Yearly Report
12th May 20224:12 pmRNS1st Quarter Results
24th Feb 20224:50 pmRNSAnnual Financial Report
11th Nov 20214:23 pmRNS3rd Quarter Results
26th Aug 20214:33 pmRNSHalf-year Report
27th May 20213:47 pmRNS1st Quarter Results
25th Feb 20214:40 pmRNSAnnual Financial Report
5th Nov 20203:45 pmRNS3rd Quarter Results
27th Aug 20204:50 pmRNSHalf-year Report
13th May 20204:16 pmRNS1st Quarter Results
27th Feb 20204:27 pmRNSAnnual Financial Report
5th Nov 20194:44 pmRNS3rd Quarter Results
29th Aug 20195:50 pmRNSHalf-year Report
16th May 20193:48 pmRNS1st Quarter Results
28th Feb 20194:10 pmRNSAnnual Financial Report
8th Nov 20183:31 pmRNS3rd Quarter Results
30th Aug 20184:38 pmRNSHalf-year Report
31st May 20184:56 pmRNS1st Quarter Results
22nd Feb 20184:35 pmRNSAnnual Financial Report
9th Nov 20174:08 pmRNS3rd Quarter Results
1st Sep 20177:00 amRNSHalf-year Report
17th May 20174:21 pmRNS1st Quarter Results
24th Feb 20177:00 amRNSFourth Quarter/ Full Year 2016 Financial Results
10th Nov 20164:19 pmRNS3rd Quarter Results
29th Sep 20162:13 pmRNSHPF New Issue of senior unsecured Notes
29th Sep 20162:05 pmRNSHPF Tender Offer
25th Aug 20163:40 pmRNSHalf-year Report
11th May 20163:55 pmRNS1st Quarter Results
25th Feb 20165:14 pmRNSFourth quarter 2015 financial results
12th Nov 20156:28 pmRNS3rd Quarter Results
27th Aug 20155:11 pmRNSHalf Yearly Report
28th May 20154:07 pmRNS1st Quarter Results
26th Feb 20156:33 pmRNSAnnual Financial Report
10th Nov 20144:04 pmRNS3rd Quarter Results
30th Jul 20144:44 pmRNSFINANCIAL RESULTS 2Q14
26th Jun 201411:56 amRNSStabilisation Notice - Hellenic Petroleum Finance
26th Jun 201410:05 amRNSAnnouncement Ebond 26 June 2014
27th May 20144:01 pmRNSHellenic Petroleum Press Release for Q1 2014
27th Feb 20146:15 pmRNSFinal Results
14th Nov 20134:06 pmRNS3rd Quarter Results
10th Sep 20131:01 pmRNSHalf Yearly Report
30th May 20133:59 pmRNS1st Quarter Results
28th Feb 20133:43 pmRNSAnnual Financial Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.